NVCA executive calls biotech one bright spot in “otherwise sleepy” IPO market

NVCACiting biotechnology as the one bright spot. the President and Chief Executive Officer of the National Venture Capital Association describes the initial public offering market as “otherwise sleepy” for venture fund-backed entities. Read his views and citations here.

Tom Ballard

By Tom Ballard, Chief Alliance Officer,
Pershing Yoakley & Associates. P.C.

eNews & Updates

Sign up to receive posts via email.

Connect With Us

Upcoming Events

Links to Partners